This inventor holds 4 USPTO granted patents and 2 published patent applications. Top assignee: Affymax, Inc.. Active years: 2009-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2009-2012
Title: The Innovations of Anne-Marie Duliege
Introduction
Anne-Marie Duliege is a prominent inventor based in Palo Alto, California. She has made significant contributions to the field of biotechnology, particularly in the development of peptide compounds that target the erythropoietin receptor.
Latest Patents
Duliege holds four patents, with her latest inventions focusing on erythropoietin receptor peptide formulations and their therapeutic uses. These peptide compounds act as agonists of the erythropoietin receptor (EPO-R) and are designed to treat disorders related to insufficient or defective red blood cell production. The patents also include pharmaceutical compositions that incorporate these peptide compounds along with recommended dosages.
Career Highlights
Anne-Marie Duliege is associated with Affymax, Inc., where she has been instrumental in advancing research and development in her field. Her work has been pivotal in creating innovative solutions for medical challenges.
Collaborations
Duliege has collaborated with notable colleagues, including Richard Stead and Kerstin Leuther, to further enhance her research and development efforts.
Conclusion
Anne-Marie Duliege's contributions to biotechnology through her innovative patents and collaborations highlight her role as a leading inventor in her field. Her work continues to impact the treatment of blood-related disorders significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile